See more : Boss Holdings, Inc. (BSHI) Income Statement Analysis – Financial Results
Complete financial analysis of FutureTech II Acquisition Corp. (FTII) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of FutureTech II Acquisition Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- PIXTA Inc. (3416.T) Income Statement Analysis – Financial Results
- Sonics & Materials, Inc. (SIMA) Income Statement Analysis – Financial Results
- Transindia Real Estate Limited (TREL.NS) Income Statement Analysis – Financial Results
- Poddar Pigments Limited (PODDARMENT.NS) Income Statement Analysis – Financial Results
- China All Nation International Holdings Group Limited (8170.HK) Income Statement Analysis – Financial Results
FutureTech II Acquisition Corp. (FTII)
Industry: Shell Companies
Sector: Financial Services
About FutureTech II Acquisition Corp.
FutureTech II Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus its search on companies in the technology industry. The company was incorporated in 2021 and is based in New Rochelle, New York.
| Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 862.70K | 100.00K | 1.31K |
| Selling & Marketing | 0.00 | 0.00 | 436.69 |
| SG&A | 862.70K | 100.00K | 438.00 |
| Other Expenses | 0.00 | 566.31K | -438.00 |
| Operating Expenses | 862.70K | 666.31K | 438.00 |
| Cost & Expenses | 862.70K | 666.31K | 438.00 |
| Interest Income | 0.00 | 1.68M | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 4.75M | 666.31K | 1.31K |
| EBITDA | 3.89M | 1.01M | 0.00 |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% |
| Operating Income | -862.70K | 342.95K | -440.00 |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 4.75M | 1.48M | 0.00 |
| Income Before Tax | 3.89M | 1.01M | -438.00 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 979.34K | 310.26K | -1.31 |
| Net Income | 2.91M | 700.02K | -438.00 |
| Net Income Ratio | 0.00% | 0.00% | 0.00% |
| EPS | 0.23 | 0.05 | 0.00 |
| EPS Diluted | 0.23 | 0.05 | 0.00 |
| Weighted Avg Shares Out | 12.80M | 15.01M | 2.50M |
| Weighted Avg Shares Out (Dil) | 12.80M | 15.01M | 2.50M |
FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance
Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity
Source: https://incomestatements.info
Category: Stock Reports